deMello D E, Chi E Y, Doo E, Lagunoff D
Am J Pathol. 1987 Apr;127(1):131-9.
Immaturity of the pulmonary surface active material synthesizing system with deficiency of surface active material in the premature lung is an accepted cause of hyaline membrane disease. Lamellar bodies, the intracellular form of surface active material, are produced and secreted from Type II pneumocytes and converted to tubular myelin in the alveolar lumen. Tubular myelin, in turn, gives rise to the surface monolayer, which has the greatest surface active property. Thus, lung sections were studied by light and electron microscopy from 35 infants who died of histologically confirmed hyaline membrane disease and 19 infants who died of other causes. Tubular myelin was not identified ultrastructurally in lungs of infants who died of hyaline membrane disease, despite the presence of abundant lamellar bodies. In contrast, 16 of 19 infants dying of other causes had easily identifiable tubular myelin in addition to lamellar bodies. The absence of tubular myelin in the hyaline membrane disease patients suggests an abnormality in the conversion of lamellar bodies to tubular myelin. The authors speculate that this abnormal lamellar body turnover may be important in the pathogenesis of hyaline membrane disease.
早产肺中肺表面活性物质合成系统不成熟且表面活性物质缺乏是公认的透明膜病病因。板层小体是表面活性物质的细胞内形式,由II型肺泡上皮细胞产生并分泌,在肺泡腔内转化为管状髓磷脂。反过来,管状髓磷脂产生具有最大表面活性的表面单分子层。因此,对35例经组织学确诊死于透明膜病的婴儿和19例死于其他原因的婴儿的肺组织进行了光镜和电镜研究。尽管存在大量板层小体,但在死于透明膜病的婴儿肺中未通过超微结构鉴定出管状髓磷脂。相比之下,19例死于其他原因的婴儿中有16例除了有板层小体之外,还很容易鉴定出管状髓磷脂。透明膜病患者中不存在管状髓磷脂提示板层小体向管状髓磷脂的转化存在异常。作者推测这种异常的板层小体更新在透明膜病的发病机制中可能很重要。